etoposide

Ukraine

Drugs containing this active substance

  • ETOPOSIDE "EBEWE"

    The drug is used in combination with other chemotherapeutic agents for the treatment of testicular cancer, small cell lung cancer, Hodgkin's disease, non-Hodgkin lymphoma, acute myeloid leukemia, malignant gestational trophoblastic disease, as well as ovarian cancer (non-epithelial in nature and platinum-resistant epithelial cancer).

    Form: concentrate for infusion solution

    Active substance Dosage
    etoposide 20 mg/ml

    ATC: L01CB01

    Manufacturer: EBEWE Pharma GmbH & Co. KG (batch release)

  • The drug is used for the treatment of small cell lung cancer, non-seminomatous testicular carcinoma, acute myelomonocytic and myelocytic leukemia, as well as for palliative therapy of non-small cell lung cancer, Hodgkin's disease, non-Hodgkin's lymphoma, and choriocarcinomas.

    Form: concentrate for infusion solution

    Active substance Dosage
    etoposide 20 mg/ml

    ATC: L01CB01

    Manufacturer: Venus Remedies Limited

  • The drug is used in combination with other chemotherapeutic agents for the treatment of testicular cancer, small cell lung cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute myeloid leukemia, gestational trophoblastic neoplasia, as well as non-epithelial and platinum-resistant epithelial ovarian cancer.

    Form: concentrate for infusion solution

    Active substance Dosage
    etoposide 20 mg/ml

    ATC: L01CB01

    Manufacturer: Farmakemi B.V.